Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes

Breast Cancer Research and Treatment

Volumn 74, Issue 1, 2002, Pages 65-76

  Goodwin, Pamela J ^a,b,c,d   Ennis, Marguerite ^a,d,e   Pritchard, Kathleen I ^a,d,e   Trudeau, Maureen E ^a,d,f   Koo, Jarley ^a,d,g   Hartwick, Warren ^a,c,d   Hoffman, Barry ^a,c,d   Hood, Nicky ^b,c  

^a Department of Medicine ^*  (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c Pediatric Oral and Maxillofacial Surgery   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^f WOMEN S COLLEGE HOSPITAL   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Breast cancer; Distant recurrence; IGFBP1; IGFBP3; Survival

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; INSULIN; METHOTREXATE; PROGESTERONE RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TAMOXIFEN;

ADULT; ARTICLE; BODY MASS; BODY SIZE; BREAST CANCER; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DIET; FEMALE; GENE EXPRESSION; HUMAN; INSULIN BLOOD LEVEL; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; OBESITY; PARTIAL MASTECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; AGED; BIOSYNTHESIS; BREAST TUMOR; GENE EXPRESSION REGULATION; METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; SURVIVAL; TUMOR RECURRENCE;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; DIET; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN 1; MIDDLE AGE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, ESTROGEN; SUPPORT, NON-U.S. GOV'T; SURVIVAL; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; MIDDLE AGED;

EID: 0035987995     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016075709022     Document Type: Article

References (35)

1. The insulin-like growth factors and breast cancer revisited
2. Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study
3. Insulin and related factors in premenopausal breast cancer risk
4. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
5. Leptin and insulin growth factor I in relation to breast cancer (Greece)
6. Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable breast cancer
7. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast
8. Serum insulin-like growth factor-I and breast cancer
9. Insulin-like growth factor-1 and breast cancer risk in postmenopausal African-American women
10. Free insulin-like growth factor-I and breast cancer risk
11. Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: The Rancho Bernardo Study
12. Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors
13. IGF-independent regulation of breast cancer growth by IGF binding proteins
14. Insulin-like growth factors and their binding proteins: Biological actions
15. Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status
16. Altered serum levels of insulin-like growth-factor binding proteins in breast cancer patients
17. Serum levels of insulin-like growth factor binding protein-3 in benign and malignant breast disease
18. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: Correlation with clinical parameters and disease-free survival
19. Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women
20. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: Detection of higher levels in tumors with poor prognostic features
21. Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer
22. Tamoxifen alters levels of serum insulin-like growth factors and binding proteins in postmenopausal breast cancer patients: A prospective paired cohort study
23. Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1
24. Plasma insulin-like growth factor I and its binding proteins 1 and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen
25. A data based approach to diet questionnaire design and testing
26. Adjustment for total energy intake in epidemiologic studies
27. Radioimmunoassay of a 26,000-Dalton plasma insulin-like growth factor-binding protein: Control by nutritional variables
28. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein
29. Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation
30. s 578T human breast cancer cells. Cell surface binding and growth inhibition
31. Crosstalk between the insulin-like growth factors and estrogens in breast cancer
32. Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactin
33. Expression of insulin-like growth factor 1 (IGF-I) in female breast cancer as related to established prognostic factors and long-term prognosis
34. Tumor makers in patients with advanced breast cancer as prognosticators: A preliminary study
35. Expression of insulin-like growth factor II in female breast cancer as related to established prognostic factors and long-term prognosis